BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -10.59% | 198.27% | |||
| Gross Profit | 10.59% | -198.27% | |||
| SG&A Expenses | -42.89% | 32.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.76% | 17.45% | |||
| Operating Income | 24.76% | -17.45% | |||
| Income Before Tax | 24.45% | -18.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.45% | -18.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.45% | -18.12% | |||
| EBIT | 24.76% | -17.45% | |||
| EBITDA | 24.61% | -17.69% | |||
| EPS Basic | 30.77% | -16.88% | |||
| Normalized Basic EPS | 30.77% | -16.88% | |||
| EPS Diluted | 30.77% | 41.70% | |||
| Normalized Diluted EPS | 30.77% | -16.88% | |||
| Average Basic Shares Outstanding | 9.14% | 1.05% | |||
| Average Diluted Shares Outstanding | 9.14% | 1.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||